Why it was recalled
Lack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets.
Product description
TESTO-100 CIII (testosterone 100 mg), 10 Sterile Pellets per carton, Rx only, Manufactured by: Advanced Pharmaceutical Technology, 132 South Central Avenue, Elmsford, NY 10523, NDC# 57377-100-01
Lot numbers, UPCs & expiration codes
Lot #: P-22-3, Exp 06-2027
Where it was sold
GA, NY, TX, Puerto Rico, United Kingdom, Malta, Greece
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0258-2026
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Oct 3, 2025
- FDA report date
- Jan 21, 2026
- Quantity
- 22,843 pellets
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Advanced Pharmaceutical Technology, Inc.
Original FDA data
Every field from FDA enforcement report D-0258-2026, exactly as published.
Show all FDA fields
- City
- Elmsford
- State
- NY
- Status
- Ongoing
- Country
- United States
- Event ID
- 97821
- Address
- 132 S Central Ave
- Code information
- Lot #: P-22-3, Exp 06-2027
- Postal code
- 10523-3509
- Report date
- Jan 21, 2026
- Product type
- Drugs
- Recall number
- D-0258-2026
- Classification
- Class II
- Recalling firm
- Advanced Pharmaceutical Technology, Inc.
- Product quantity
- 22,843 pellets
- Reason for recall
- Lack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- TESTO-100 CIII (testosterone 100 mg), 10 Sterile Pellets per carton, Rx only, Manufactured by: Advanced Pharmaceutical Technology, 132 South Central Avenue, Elmsford, NY 10523, NDC# 57377-100-01
- Distribution pattern
- GA, NY, TX, Puerto Rico, United Kingdom, Malta, Greece
- Recall initiation date
- Oct 3, 2025
- Initial firm notification
- Letter
- Center classification date
- Jan 14, 2026